GeminIQ Website Logo

Viewing BNGO free

Subscribe for full history, 50+ metrics, screener, watchlist...

Bionano Genomics, Inc.

BNGO

Companies in Laboratory Analytical Instruments

Bionano Genomics, Inc. (BNGO) — SEC Financial Statements & Analysis

Bionano Genomics, Inc. (BNGO) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
33344991016183515
Available For Sale Securities Debt Securities Curr…
111619131503913492962
Accounts Receivable Net Current
455335568998
Inventory Net
-----------32
Prepaid Expense And Other Assets Current
555333455665
Restricted Cash Current
-------11----
Restricted Investments Current
-10101111111102435--
Restricted Cash And Investments Current
10-----------
Assets Current
394549434539476186140105123
Restricted Cash Noncurrent
-00000000000
Property Plant And Equipment Net
141516171819202525232120
Operating Lease Right Of Use Asset
333412345667
Finance Lease Right Of Use Asset
333333333444
Intangible Assets Net Excluding Goodwill
3467810113032343638
Other Assets Noncurrent
3322233677103
Goodwill
---------0077
Assets
65747976787787129158214182271
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
5666779910101512
Accrued Liabilities Current
45534666118128
Contract With Customer Liability Current
111111111111
Operating Lease Liability Current
111123222222
Finance Lease Liability Current
000000000000
Business Combination Contingent Consideration Liab…
---------01010
Liabilities Current
2123232426373337591004033
Operating Lease Liability Noncurrent
323300223445
Finance Lease Liability Noncurrent
333444444444
Contract With Customer Liability Noncurrent
000000000000
Business Combination Contingent Consideration Liab…
-----00610111515
Liabilities
2729293130413849751186357
Stockholders Equity
Preferred Stock Value
000000000000
Common Stock Value
000000000000
Additional Paid In Capital Common Stock
765764761749745729720709695677656640
Retained Earnings Accumulated Deficit
-728-720-712-703-696-693-673-629-613-581-537-425
Accumulated Other Comprehensive Income Loss Net Of…
000-0002-0-00-0-0
Stockholders Equity
37445045483549808396119215
Liabilities And Stockholders Equity
65747976787787129158214182271
Preferred Stock Par Or Stated Value Per Share
000000000000
Preferred Stock Shares Authorized
101010101010101010101010
Preferred Stock Shares Outstanding
000000000000
Preferred Stock Shares Issued
000000000000
Common Stock Par Or Stated Value Per Share
000000000000
Common Stock Shares Authorized
400400400400400400400400400400400400
Common Stock Shares Issued
797578828790887158555
Shares Outstanding
7975788287908871581283299

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-6.40%-8.00%----------
20250.27%-9.89%-21.12%24.30%-40.19%-43.93%14.29%8.16%-11.56%-11.64%-21.23%-20.55%
20245.43%-26.09%-31.52%13.95%6.98%-27.91%-11.54%23.08%-66.73%54.12%33.33%14.70%
2023----7.23%-26.99%-69.64%22.06%38.97%-10.29%-6.72%-33.61%-10.08%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
1.84
1.98
2.12
1.76
1.70
1.06
1.43
1.63
1.46
1.40
2.60
3.66
Quick Ratio
1.61
1.75
1.89
1.64
1.60
0.97
1.29
1.50
1.38
1.34
2.46
2.53
Working Capital
17.75M
22.44M
25.82M
18.48M
18.52M
2.15M
14.03M
23.39M
27.11M
40.09M
64.34M
89.08M
Leverage & Debt
Debt to Equity
0.73
0.66
0.59
0.68
0.63
1.17
0.79
0.61
0.91
1.23
0.53
0.26
Interest Coverage TTM
-
-
-
-
-
-852.32
-23.31
-36.59
-40.37
-42.05
-772.27
-494.13
Debt Ratio
0.42
0.40
0.37
0.40
0.39
0.54
0.44
0.38
0.48
0.55
0.35
0.21
Efficiency & Turnover
Asset Turnover TTM
0.40
0.38
0.35
0.27
0.24
0.21
0.25
0.18
0.17
0.14
0.13
0.11
Days Sales Outstanding TTM
47.55
63.71
62.54
64.87
74.80
83.44
76.57
69.19
73.51
82.57
78.72
72.18
Receivables Turnover TTM
7.68
5.73
5.84
5.63
4.88
4.37
4.77
5.28
4.97
4.42
4.64
5.06
Per Share Metrics
Diluted EPS TTM
-2.88
-2.42
-3.61
-10.80
-15.53
-22.03
-23.72
-45.32
-64.50
-102.15
-100.65
-72.10
Free Cash Flow Per Share TTM
-1.76
-1.50
-1.75
-3.79
-8.08
-13.56
-16.11
-23.35
-34.39
-55.00
-71.72
-81.26
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
46.97%
46.25%
45.97%
5.05%
1.74%
1.23%
-1.79%
28.97%
27.54%
26.49%
26.57%
25.36%
Operating Profit Margin TTM
-114.03%
-116.95%
-127.94%
-262.91%
-285.71%
-337.87%
-350.97%
-509.32%
-556.51%
-595.98%
-677.83%
-465.70%
Net Profit Margin TTM
-109.95%
-92.59%
-134.36%
-271.02%
-294.05%
-363.98%
-407.34%
-557.98%
-605.26%
-643.74%
-676.22%
-464.96%
Growth Metrics
Net Revenue Growth (1Y)
0.96%
-7.37%
-13.84%
-25.02%
-24.04%
-14.79%
-0.82%
16.08%
26.93%
29.90%
29.82%
35.12%
Net Income Growth (1Y)
-62.25%
-76.44%
-71.58%
-63.58%
-63.10%
-51.82%
-40.26%
39.30%
62.26%
75.34%
94.47%
38.47%
EPS Growth (1Y)
-81.47%
-89.00%
-84.76%
-76.17%
-75.92%
-78.43%
-76.43%
-37.15%
-10.07%
43.74%
60.97%
25.54%
Valuation Metrics
P/E TTM
-0.41
-0.63
-0.47
-0.30
-0.18
-0.79
-1.14
-0.90
-1.03
-1.11
-1.81
-5.08
P/B
0.34
0.38
0.37
0.50
0.31
2.50
3.16
2.29
2.83
2.68
3.45
3.46
P/S TTM
0.45
0.58
0.64
0.82
0.53
2.87
4.64
5.02
6.25
7.15
12.21
23.60
Market Cap
12.85M
16.66M
18.26M
22.57M
15.03M
88.46M
154.55M
183.76M
234.17M
258.10M
410.53M
743.76M
Enterprise Value
11.64M
15.88M
18.94M
22.78M
15.19M
82.69M
149.17M
165.76M
221.85M
243.61M
379.83M
732.39M
Calculated Values
Free Cash Flow TTM
-19.30M
-16.35M
-18.67M
-26.06M
-43.56M
-68.92M
-92.20M
-105.18M
-120.90M
-125.18M
-161.96M
-165.14M
Net Debt
-1.20M
-780.00K
681.00K
203.00K
158.00K
-5.77M
-5.38M
-18.00M
-12.32M
-14.49M
-30.70M
-11.37M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2023-06-13Purchase
Owner: Mamuszka, Hannah
Title: -
Shares: 65,789
Price/Share: $0.76
Value: $49,999.64
Shares Owned: 65,789
Relationship: Director
Ownership: Direct
2023-05-16Purchase
Owner: Holmlin, R. Erik
Title: President and CEO
Shares: 15,000
Price/Share: $0.64
Value: $9,600.00
Shares Owned: 806,474
Relationship: Director,Officer
Ownership: Direct
2023-05-12Purchase
Owner: Stewart, Christopher P.
Title: Chief Financial Officer
Shares: 50,000
Price/Share: $0.67
Value: $33,500.00
Shares Owned: 281,373
Relationship: Officer
Ownership: Direct
2022-08-15Sale
Owner: Linney, Yvonne
Title: -
Shares: 20,000
Price/Share: $3.62
Value: $72,400.00
Shares Owned: -
Relationship: Director
Ownership: Direct
2022-05-16Purchase
Owner: Barker, David L
Title: -
Shares: 10,000
Price/Share: $1.60
Value: $16,000.00
Shares Owned: 13,894
Relationship: Director
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
4.59%
Inst. Shares: 503,913
Shares Outstanding: 10,979,000
2025-12-31
5.03%
Inst. Shares: 547,711
Shares Outstanding: 10,890,000
2025-09-30
2.10%
Inst. Shares: 224,087
Shares Outstanding: 10,676,000
2025-06-30
0.83%
Inst. Shares: 57,251
Shares Outstanding: 6,882,000
2025-03-31
2.77%
Inst. Shares: 149,100
Shares Outstanding: 5,388,000

Research Faster.
Invest Smarter.

Bionano Genomics, Inc. (BNGO) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.